Found 5 matching trials
A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
PHASE2Primary Objective:
To evaluate the effect of caplacizumab on prevention of...
Location
Investigational Site Number 3920009
Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura
PHASE3The study was a Phase III, double-blind, placebo-controlled, randomized stu...
Location
Investigator Site
Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients
PHASE2This is a multicenter, randomized and open-label Phase II study to compare ...
Location
Multiple Locations
Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)
PHASE3The objectives of this study were to evaluate long-term safety and efficacy...
Location
Investigator site
Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
PHASE2This study was a Phase II, single-blind, randomized, placebo-controlled tri...
Location
Investigator Site